FIELD: chemistry.
SUBSTANCE: invention describes a compound of formula (III) 
in form of a free base or an acid addition salt, use thereof as a pharmaceutical agent for preventing, treating and/or inhibiting progression of psychotic and neurodegenerative disorders, as well as pharmaceutical compositions based on said compound.
EFFECT: novel compound which can be used to prevent, treat or inhibit progression of diseases or a pathologic condition in which nAChR α7 activation participates or plays a role.
8 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| [(1H-INDOL-5-YL)-HETEROARYLOXY]-1-AZABICYCLO[3,3,1]NONANES AS CHOLINERGIC LIGANDS N-ACHR, APPLICABLE FOR PSYCHOTIC AND NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2471797C2 |
| 1-AZABICYCLO[3,3,1]NONANES DERIVATIVES | 2005 |
|
RU2445313C2 |
| 3-(HETEROARYLOXY)-2-ALKYL-1-AZABICYCLOALKYL DERIVATIVES AS LIGANDS OF ALPHA-7-nAChR (NICOTINIC ACETYLCHOLINE RECEPTORS), MEANT FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES | 2005 |
|
RU2402551C2 |
| RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES | 2008 |
|
RU2417984C1 |
| AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
| LIGANDS OF NICOTINE RECEPTOR α, THEIR OBTAINING AND APPLICATION | 2005 |
|
RU2418797C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING POSITIVE MODULATOR OF NICOTINE RECEPTOR AGONIST AND AGONIST OF NICOTINE RECEPTOR, METHOD FOR TREATMENT | 1999 |
|
RU2225203C2 |
| AMIDES OF DIAZABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINE RECEPTORS AND PHARMACEUTIC COMPOSITION AND METHODS OF TREATMENT WITH THEIR APPLICATION | 2007 |
|
RU2448969C2 |
| SYNTHESYS OF HYDRATED 4-AMINO-5-CHLORO-2-METHOXY-N-(1-AZA-BICYCLO[3,3,1]NON-4-YL)BENZAMIDE HYDROCLORIDE POLYMORPH | 2004 |
|
RU2337102C2 |
| AMIDES OF DIASABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINIC RECEPTORS | 2007 |
|
RU2517693C2 |
